[Ip-health] MSF position on entry of the Medicines Patent Pool into Hepatitis C and TB

Rohit MALPANI Rohit.MALPANI at paris.msf.org
Fri May 8 06:37:27 PDT 2015

Médecins Sans Frontières (MSF) supports the Medicines Patent Pool (MPP)
playing a key role in facilitating and accelerating entry of new and
critical medical commodities into markets, including by reducing
intellectual property (IP) barriers that undermine innovation and access.
This year, the UNITAID Board will evaluate whether the Medicines Patent
Pool should expand its mandate to negotiate voluntary licenses for
hepatitis C virus (HCV) and tuberculosis (TB) medicines. MSF supports the
proposition that the MPP immediately begin work to facilitate voluntary
licenses for TB medicines and to manage an IP pool for development of
future TB regimens. The MPP should consider expanding its mandate to HCV
only after certain conditions are met and after careful consideration of
key issues.


More information about the Ip-health mailing list